U.S. Markets open in 6 hrs 15 mins

TG Therapeutics, Inc. (TGTX)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
11.95+0.50 (+4.37%)
At close: 4:00PM EDT
People also watch
FOLDESPRAUPHPTCTAGIO
  • 12 million shorts looking to cover.. 12 MILLION
    Imageyourreactiongifs
  • Guess the close.
    I say above 12.40
  • It's only the beginning my friends.... I'll be here at $100
  • Shorts are bringing this down again :/
  • Knew this was coming. Ironically, before investing in this gold star company, I made an appointment with Dr. Sharman for next month. Sure wish I had bought more when it was not n the 9s😊
  • The next month, going into ASCO and then the European presentations will be a very informative time for the Wall street investment houses. Look for new initiated coverage and upgraded price targets This stock is about to move into t low 20's folks.
  • MAGIC IS BACK!!... HOLD ON..
    Imageheckyeahreactiongifs
  • Will take 4.37% up any day
  • this is just sad
  • How is this stock not 15 today blows my mind
  • Good day today folks. Let's keep things positive. I like the way we are looking going into ASCO. A lot of excitement in this stock right now. Cheers!
  • However shorted at $12.90 today are buying at $11.90 now.....
  • Just cashed out of my position in PBYI for a nice gain today. Just like TGTX, heavy short interest...and they were dead wrong. It can happen... :)
  • Continued enrollment without modification baby!!
    Imagesomenerv
  • Good news is out this morning .Safety profile is key. We are on the right track. Patience will be rewarded.
  • 11 close
  • They are stuck!!!
    Imagesrsfunny
  • TIME TO COVER 12M
    Imagedog-lovers--club
  • EHA DLBCL Conclusion
    Conclusion
    The combination of UTX, TGR-1202, and bendamustine has exhibited manageable toxicity with significant activity in advanced DLBCL and FL pts including an encouraging 42% CR rate (45% in DLBCL and 38% in FL). Enrollment continues at the 800 mg TGR-1202 dose level with the use of growth factor prophylaxis. Safety and efficacy data for all pts will be updated at the meeting. Based upon the early activity of the triplet, future registration directed studies are being planned.
  • During a Quiet Period, a publicly listed company cannot make any announcements about anything that could cause a normal investor to change their position on the company's stock.
    Imagegiphygiff